Oncolytic vaccinia virus: a silver bullet?

This publication has 26 references indexed in Scilit:

• 5-Fluorouracil Selectively Kills Tumor-Associated Myeloid-Derived Suppressor Cells Resulting in Enhanced T Cell–Dependent Antitumor Immunity
  Cancer Research, 2010
• The immunologic aspects of poxvirus oncolytic therapy
  Cancer Immunology, Immunotherapy, 2009
• Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial
  The Lancet Oncology, 2008
• Targeted delivery of a suicide gene to human colorectal tumors by a conditionally replicating vaccinia virus
  Gene Therapy, 2008
• Systemic Chemotherapy for Advanced Non-Small Cell Lung Cancer: Recent Advances and Future Directions
  The Oncologist, 2008
• Oncolytic virotherapy for ovarian carcinomatosis using a replication-selective vaccinia virus armed with a yeast cytosine deaminase gene
  Cancer Gene Therapy, 2007
• History of Oncolytic Viruses: Genesis to Genetic Engineering
  Molecular Therapy, 2007
• 5-Fluorouracil incorporation into RNA and DNA in relation to thymidylate synthase inhibition of human colorectal cancers
  Annals of Oncology, 2004
• Vaccinia virus: a suitable vehicle for recombinant vaccines?
  Archives of Virology, 1989
• Infectious poxvirus vectors have capacity for at least 25 000 base pairs of foreign DNA
  Gene, 1983